DeutschNewstral
Article
The Times of India on 2021-09-30 04:03
'Delay in WHO approval for Covaxin a serious setback for India'
Related news
- India-made Covaxin gets WHO approval, can be used globallyThe Times of India
- BCovaxin: Concern over 'rushed' approval for India Covid jabbbc.co.uk
- Diwali gift to India: Covaxin gets WHO approvalThe Times of India
WHO’s approval for Covaxin likely this monthThe Hindu- Drug Controller General approves Covishield and Covaxin in India for ‘emergency use’The Hindu
- Covishield, Covaxin to get full approval but won’t be retailingThe Times of India
- 'Bharat Biotech yet to apply for Covaxin approval by Canada'The Times of India
- Covaxin approval: WHO seeks additional clarifications for final 'risk-benefit assessment'The Times of India
- Coronavirus live updates | Govt reviews process to get WHO approval for CovaxinThe Hindu
- Coronavirus | Central panel recommends approval for CovaxinThe Hindu
- WHO's approval for Covaxin likely this monthThe Times of India
- WHO decision on Covaxin approval likely soonThe Times of India
- Won't recognise your vaccine certificates if you don't clear Covaxin, Covishield: India to EUThe Times of India
- Covaxin offers protection against double mutant variant found in India: studyThe Hindu
- Covaxin development has proved India is more than pharmacy of world: ICMR chiefThe Hindu
- BAstraZeneca: Nigeria suffers setback as India prioritises vaccinating citizensbusinessday.ng
- Coronavirus | After SII, Bharat Biotech seeks DCGI approval for CovaxinThe Hindu
- Scientists divided over restricted use approval for CovaxinThe Hindu
- Covaxin: Government reviews process to get WHO approvalThe Hindu